XML 13 R6.htm IDEA: XBRL DOCUMENT v3.25.3
Consolidated Statements of Cash Flows - USD ($)
9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Cash flows from operating activities:    
Net increase (decrease) in net assets resulting from operations $ 45,789,360 [1] $ 21,763,615 [2],[3]
Adjustments to reconcile net increase (decrease) in net assets resulting from operations to net cash provided by (used in) operating activities:    
Net change unrealized (appreciation) depreciation on derivative instruments 875,296 587,496
Net change unrealized (appreciation) depreciation on foreign currency and other transactions (2,194,761) (686,533)
Net realized (gain) loss on investments (6,144,647) (2,138,708)
Net realized (gain) loss on derivative instruments 1,083,416 0
Net realized (gain) loss on foreign currency and other transactions (14,689) 1,621
Payment-in-kind interest capitalized (4,321,405) (3,380,583)
Net accretion of discount and amortization of premium (9,411,671) (4,778,617)
Amortization of deferred financing costs 570,931 516,669
Amortization of offering costs 569,023 1,108,429
Purchases of investments (633,689,223) (450,677,120)
Cash settlement of derivatives (1,091,562) 0
Proceeds from sale of investments and principal repayments 377,329,070 193,363,481
Changes in operating assets and liabilities:    
Interest receivable (189,809) (4,878,770)
Deferred offering costs 0 (1,223,320)
Receivable for investments sold (2,394,769) (4,663,600)
Due from Advisor 74,454 607,298
Other assets (95,137) (13,347)
Payable for investments purchased 11,710,302 23,891,032
Due to Advisor and affiliates 205,710 (35,045)
Management fee payable 530,997 457,129
Income incentive fee payable 1,713,460 643,020
Accrued capital gains incentive fee (371,180) (188,052)
Interest and credit facility fees payable 1,157,901 757,268
Accrued expenses and other liabilities 859,682 454,439
Net cash provided by (used in) operating activities (207,636,262) (225,840,484)
Cash flows from financing activities:    
Proceeds from Secured Credit Facility 230,619,000 83,016,000
Repayment of Secured Credit Facility (128,804,745) 0
Deferred financing cost paid (75,000) 0
Distributions paid in cash (17,400,245) (11,358,764)
Deferred offering costs paid (340,793) 0
Proceeds from issuance of common shares 126,581,146 157,391,157
Redemptions paid in cash (545,604) 0
Net cash provided by (used in) financing activities 210,033,759 229,048,393
Net increase (decrease) in cash, cash equivalents and restricted cash 2,397,497 3,207,909
Cash, cash equivalents and restricted cash, beginning of year 37,743,294 73,025,293
Cash, cash equivalents and restricted cash, end of year 40,140,791 76,233,202
Supplemental information and non-cash activities:    
Cash paid for interest 19,988,518 15,999,514
Restructuring of portfolio investments (Note 3) 23,085,896 0
Reinvestment of distributions 40,762,486 19,888,261
Accrued but unpaid deferred offering cost 16,428 274,585
Non-controlled/Non-affiliated Investments [Member]    
Adjustments to reconcile net increase (decrease) in net assets resulting from operations to net cash provided by (used in) operating activities:    
Net change unrealized (appreciation) depreciation on investments 10,744,325 2,671,714
Net realized (gain) loss on investments (6,144,647) (2,138,708)
Controlled/affiliated Investments [Member]    
Adjustments to reconcile net increase (decrease) in net assets resulting from operations to net cash provided by (used in) operating activities:    
Net change unrealized (appreciation) depreciation on investments $ (931,336) $ 0
[1] There were no Class D shares outstanding as of September 30, 2025.
[2] Common Shares issued and outstanding as of June 23, 2024, were issued pursuant to the Private Offering. As part of the Public Offering effective June 24, 2024, the Common Shares issued pursuant to the Private Offering became Class I shares. Common Shares issued pursuant to the Private Offering are reclassified as Class I shares to conform with current period presentation.
[3] There were no Class S or Class D shares outstanding as of September 30, 2024.